Academic literature on the topic 'HIV treatment adherence'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HIV treatment adherence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HIV treatment adherence"

1

Cooper, Curtis L., and Ed Mills. "Comparison of first antiretroviral treatment duration and outcome in HIV, HIV–HBV and HIV–HCV infection." International Journal of STD & AIDS 18, no. 8 (2007): 546–50. http://dx.doi.org/10.1258/095646207781439838.

Full text
Abstract:
Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection may differentially influence HIV treatment duration and outcome. This was assessed at The Ottawa Hospital Immunodeficiency Clinic in first-time highly active antiretroviral therapy (HAART) recipients visited between January 2000 and December 2004. Of 968 patients, 526/700 (75%) HIV, 173/230 (75%) HIV–HCV and 30/38 (79%) HIV–HBV-infected patients initiated HAART. Co-infected patients stopped treatment sooner (HBV – 10 months, HCV – 9 months) than HIV mono-infected (17 months) ( P<0.001). Injection drug history predicted shorter
APA, Harvard, Vancouver, ISO, and other styles
2

Wagner, Glenn, Karen Chan Osilla, Jeffrey Garnett, et al. "Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients." AIDS Research and Treatment 2011 (2011): 1–7. http://dx.doi.org/10.1155/2011/903480.

Full text
Abstract:
Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes.Methods. Chart abstracted and survey data were collected on 72 HIV patients who had received pegylated interferon and ribavirin to assess correlates of treatment adherence, completion, and sustained virologic response (SVR).Results. Nearly half (46%) the sample had active psychiatric problems and 13% had illicit drug use at treatment onset; 28% reported <100% treatment adheren
APA, Harvard, Vancouver, ISO, and other styles
3

Sharma, B., and K. Joshi. "Treatment adherence of antiretroviral therapy among people living with HIV/AIDS." Journal of Chitwan Medical College 6, no. 3 (2017): 56–61. http://dx.doi.org/10.3126/jcmc.v6i3.16701.

Full text
Abstract:
Adherence to Antiretroviral therapy (ART)is a principle predictor for the success of Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome treatment. Highly Active Antiretroviral Therapy (HAART) has led to the reduction of mortality and the improvement of the quality of people living with HIV/AIDS. It has been estimated that at least 95% adherence with therapy is required to reduce HIV viral load. Non-adherence to treatment can lead to inadequate suppression of viral replication, continued destruction of CD4 cells, progressive decline in immune function and disease progression.
APA, Harvard, Vancouver, ISO, and other styles
4

Stirratt, Michael J., and Christopher M. Gordon. "HIV Treatment Adherence Research and Intervention." Journal of HIV/AIDS & Social Services 6, no. 1-2 (2007): 9–22. http://dx.doi.org/10.1300/j187v06n01_02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miguez-Burbano, Maria Jose, Luis Espinoza, and John E. Lewis. "HIV Treatment Adherence and Sexual Functioning." AIDS and Behavior 12, no. 1 (2007): 78–85. http://dx.doi.org/10.1007/s10461-006-9197-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hornschuh, Stefanie, Janan Janine Dietrich, Celokuhle Tshabalala, and Fatima Laher. "Antiretroviral Treatment Adherence: Knowledge and Experiences among Adolescents and Young Adults in Soweto, South Africa." AIDS Research and Treatment 2017 (2017): 1–8. http://dx.doi.org/10.1155/2017/5192516.

Full text
Abstract:
Human immunodeficiency virus (HIV) management of adolescents and young adults (AYAs) is particularly pertinent to sub-Saharan Africa, where the pediatric HIV burden is marked. Antiretroviral treatment (ART) adherence is a major challenge for AYAs. This qualitative study explored knowledge and experiences of adherence amongst AYAs attending treatment at the Perinatal HIV Research Unit (PHRU), Soweto, South Africa. Four focus group discussions (FGDs) and eight in-depth interviews (IDIs) were conducted with HIV-infected 15–25-year-old ART recipients. Transcripts were coded thematically. Participa
APA, Harvard, Vancouver, ISO, and other styles
7

Sánchez Peña, Sara, María del Mar Pastor Bravo, Miguel Ángel Cánovas Tomás, Pilar Almansa-Martínez, Caridad Peñalver Guillen, and Ismael Jiménez-Ruiz. "Factores relacionados con la adherencia al tratamiento antirretroviral en mujeres con VIH: Un estudio mixto con diseño secuencial." Enfermería Global 20, no. 2 (2021): 1–34. http://dx.doi.org/10.6018/eglobal.437711.

Full text
Abstract:
Introducción: El VIH/Sida afecta cada vez a más mujeres. La adherencia al tratamiento antirretroviral es decisiva en la calidad de vida de las personas infectadas. Objetivos: El objetivo del estudio es determinar el grado de adherencia manifestada en un grupo de mujeres con VIH/Sida, con TAR e identificar los factores y circunstancias que influyen en su adherencia.Metodología: Se ha realizado un estudio con diseño mixto secuencial explicativo. Los sujetos de estudio son 86 mujeres diagnosticadas con VIH/Sida en tratamiento con TARGA. Resultados: Se recogieron datos cualitativos de 18 de ellas.
APA, Harvard, Vancouver, ISO, and other styles
8

Stirratt, Michael J., and Christopher M. Gordon. "Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research." Current HIV/AIDS Reports 5, no. 4 (2008): 186–92. http://dx.doi.org/10.1007/s11904-008-0027-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wagner, Glenn J., Mary Slaughter, and Bonnie Ghosh-Dastidar. "Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda." Journal of the International Association of Providers of AIDS Care (JIAPAC) 16, no. 1 (2016): 91–97. http://dx.doi.org/10.1177/2325957416677121.

Full text
Abstract:
We examined the relationship between depression (symptom type, diagnostic severity, and change over time) and adherence to HIV antiretroviral therapy (ART) with data from 3 longitudinal studies (N = 1021) of patients starting ART in Uganda. The Patient Health Questionnaire was used to assess depressive symptoms (total score; somatic and cognitive subscales) and categorize severity level. At baseline, 9% had major depression and 30% had minor depression; 82% were adherent (reported no missed ART doses in the past 7 days) at month 6 and 85% at month 12. Controlling for demographic and medical co
APA, Harvard, Vancouver, ISO, and other styles
10

Johnson, Mallory O., Torsten B. Neilands, Samantha E. Dilworth, Stephen F. Morin, Robert H. Remien, and Margaret A. Chesney. "The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)." Journal of Behavioral Medicine 30, no. 5 (2007): 359–70. http://dx.doi.org/10.1007/s10865-007-9118-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HIV treatment adherence"

1

Södergård, Björn. "Adherence and Readiness to Antiretroviral Treatment." Doctoral thesis, Uppsala University, Department of Pharmacy, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7282.

Full text
Abstract:
<p>Antiretroviral therapy places extraordinarily high demands on adherence, since non-adherence affects both individuals and society due to the spread of resistant viral strains. The aims of the thesis were to investigate the prevalence of adherence in Swedish HIV-infected patients, changes in adherence over time, and factors associated with adherence, including patients’ readiness to adhere. Further, to investigate the collaboration between nurses, doctors and pharmacists after the introduction of a HIV-clinic satellite pharmacy. Data were collected via two cross-sectional patient surveys in
APA, Harvard, Vancouver, ISO, and other styles
2

Masokoane, Kgomotso Quentinne. "Adherence and non-adherence to antiretroviral treatment in HIV people in Port Elizabeth." Thesis, Nelson Mandela Metropolitan University, 2009. http://hdl.handle.net/10948/1185.

Full text
Abstract:
The introduction of antiretroviral drugs (ARVs) in 1996 transformed the treatment of HIV and AIDS, improving the quality and greatly prolonging the lives of many infected people. HIV (Human Immunodeficiency Virus) is the virus that is believed to cause AIDS. AIDS (Acquired Immune Deficiency Syndrome) is the collection of illnesses or symptoms that ultimately results in death. Antiretroviral (ARVs) drugs or Highly Active Antiretroviral Therapy (HAART) is the treatment that has been applied to combat the HI virus in a bid to slow down the progression of AIDS and ultimately prolong the life of th
APA, Harvard, Vancouver, ISO, and other styles
3

Phalafala, Mathatho Samuel. "The effects of HIV status disclosure on antiretroviral treatment adherence." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96973.

Full text
Abstract:
Thesis (MSc)--Stellenbosch University, 2015.<br>ENGLISH ABSTRACT: Successful antiretroviral therapy (ART) depends on appropriate use of antiretroviral agents; which ultimately prevents replication of Human Immunodeficiency Virus (HIV) thus delaying clinical progression of the disease. This study explored how HIV status disclosure affects adherence to antiretroviral therapy at Mamelodi Hospital, using a convenience sampling method with a sample size of 50 adults above 18 years who were on treatment for a minimum of two years prior to the study. An interview protocol was used to uncover patient
APA, Harvard, Vancouver, ISO, and other styles
4

Barnes, Shelly Marie. "Investigating the Impact of Patient-Provider Communication on HIV Treatment Adherence." Thesis, University of North Texas, 2016. https://digital.library.unt.edu/ark:/67531/metadc849690/.

Full text
Abstract:
Today over 1.1 million people are living with HIV/AIDS in the United States; over the last 4 decades mortality rates have decreased largely made in part because of advancement in awareness and treatment options. Treatment adherence has long been considered a vital component in decreasing HIV/AIDS related mortality and has proven to reduce the risk of transmission. However not all patients take their medicine as prescribed. This research study, sponsored by The North Central Texas HIV Planning Council explored how Patient and Provider communication impacted treatment adherence. By utilizing a m
APA, Harvard, Vancouver, ISO, and other styles
5

Ngugi, Pearl. "Response and adherence of HIV positive women to cervical cancer treatment." Thesis, Nelson Mandela Metropolitan University, 2011. http://hdl.handle.net/10948/d1014129.

Full text
Abstract:
It is estimated that 6742 South African women are diagnosed with cervical cancer and 3681 women die from the disease every year. In 1993, The Centers for Disease Control declared cervical cancer an Acquired Immunodeficiency Syndrome defining illness. Apart from persistent human papillomavirus infection, HIV infection is the most common co-factor contributing to cervical cancer in South Africa. Studies have noted that in HIV positive women, there has been an occurrence of faster progression to more advanced stages of cervical cancer with high cases of treatment failure and recurrence. There is
APA, Harvard, Vancouver, ISO, and other styles
6

Kurtyka, Donald E. "The Effects of a Structured Adherence Intervention to HAART on Adherence and Treatment Response Outcomes." Scholar Commons, 2007. https://scholarcommons.usf.edu/etd/350.

Full text
Abstract:
Background: Adherence to antiretroviral (ARV) medications in excess of 90-95% is necessary for optimal response to suppress HIV replication and to maintain and/or restore immune function. A number of interventions have been shown to improve ARV adherence, but no research has been conducted which evaluates proactive monitoring of pharmacy refill adherence and subsequent intervention when inadequate adherence is identified. Purpose: The purpose of this project was to compare treatment response, pharmacy refill adherence and self-reported medication adherence between two groups of patients: those
APA, Harvard, Vancouver, ISO, and other styles
7

Usman, Samuel. "Factors which affect optimal adherence to antiretroviral medications." Thesis, Stellenbosch : University of Stellenbosch, 2010. http://hdl.handle.net/10019.1/4181.

Full text
Abstract:
Thesis (MPhil (Industrial Psychology. Africa Centre for HIV/AIDS Management))--University of Stellenbosch, 2010.<br>ENGLISH ABSTRACT: The advent of anti-retroviral therapy (ART) has bought hope and reprieve in a previously hopeless situation where there was no available drug to combat the virus with the result that AIDS deaths from chronic, untreated HIV infection became the major cause of morbidity and mortality especially in sub-Saharan Africa where the disease burden is highest. Since March 19, 1987, when the FDA approved Zidovudine for the treatment of AIDS, there has been great impro
APA, Harvard, Vancouver, ISO, and other styles
8

Engel, Tania. "Measuring adherence levels to antiretroviral treatment (ART) and assessing certain factors affecting adherence in a state primary health care clinic, Mitchells Plain Community Health Centre, South Africa." Thesis, Stellenbosch : University of Stellenbosch, 2015. http://hdl.handle.net/10019.1/97236.

Full text
Abstract:
Objective. Measuring adherence levels and assessing the impact on adherence to ART (antiretroviral treatment) of the factors: disclosure to partner, partner support, other support and length of time between diagnosis and ART commencement, in a state-run ART clinic at Mitchells Plain Community Health centre. Design. A retrospective case control study was conducted and the information was obtained by means of a file audit. Methods. Every 5th file was selected for the study and 199 participants were chosen based on the inclusion and exclusion criteria. Adherence for each patient was measured u
APA, Harvard, Vancouver, ISO, and other styles
9

Mbunyuza, Lungelwa. "Treatment adherence in TB/HIV co-infected patients in Mount Frere, Eastern Cape." University of Western Cape, 2020. http://hdl.handle.net/11394/8051.

Full text
Abstract:
Master of Public Health - MPH<br>Adequate levels of adherence to treatment for tuberculosis (TB) and HIV at the same time poses a problem for public health in South Africa. TB/HIV co-infected patients face many potential barriers to adherence to treatment for both conditions. There is a need for more knowledge about factors influencing treatment adherence in co-infected patients on concomitant treatment. The aim of this study was to explore the barriers and facilitators to treatment adherence among people co-infected with TB/HIV living in the Alfred Nzo District, Eastern Cape, in order to iden
APA, Harvard, Vancouver, ISO, and other styles
10

Weinberger, Beverley Slome Kloss Jacqueline D. "Posttraumatic stress in adolescents with HIV and its relationship with treatment adherence : the role of health beliefs /." Philadelphia, Pa. : Drexel University, 2010. http://hdl.handle.net/1860/3221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HIV treatment adherence"

1

Gupta, Indrani. Determinants of adherence in the antiretroviral treatment programme of the government of India. Institute of Economic Growth, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ka'opna, Lana Sue, and Nathan L. Linsk, eds. HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sue, Ka'opua Lana, and Linsk Nathan L, eds. HIV treatment adherence: Challenges for social services. Haworth Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Linsk, Nathan L., and Lana Sue Ka'opna. HIV Treatment Adherence: Challenges for Social Services. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lana Sue, Ph.D. Ka'opua (Editor) and Nathan L. Linsk (Editor), eds. HIV Treatment Adherence: Challenging for Social Services (Journal of HIV/AIDS & Social Services) (Journal of HIV/AIDS & Social Services). Haworth Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Weiss, Jeffrey J., and Michael J. Stirratt. Psychiatric Aspects of Care Engagement and Medication Adherence in Antiretroviral-Based HIV Treatment and Prevention. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0029.

Full text
Abstract:
Care engagement and treatment adherence are directly related to HIV treatment outcomes and to mortality. Active drug use and psychiatric illness such as depressive and addictive disorders are significant barriers to care engagement and treatment adherence among persons living with HIV and those at high risk for HIV infection and eligible for pre-exposure prophylaxis (PrEP). This chapter addresses (1) psychiatric aspects of PrEP for HIV prevention, (2) the care continuum for individuals living with HIV infection, (3) psychiatric determinants of HIV care engagement, (4) behavioral interventions
APA, Harvard, Vancouver, ISO, and other styles
7

Cozza, Kelly L., Gary H. Wynn, Glenn W. Wortmann, Scott G. Williams, and Rita Rein. Psychopharmacological Treatment Issues in HIV/AIDS Psychiatry. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0042.

Full text
Abstract:
Attention to pharmacokinetics and pharmacodynamics and an understanding of intended effects, side effects, toxicities, and drug interactions are imperative when treating persons with HIV/AIDS. This chapter includes an essential review of drug interaction principles and an overview of current antiretroviral treatment (ART) and known side effects, toxicities, and drug interactions, in text and table format. The chapter concludes with a presentation of psychotropic-antiretroviral treatment issues. Most psychotropics are effective in the treatment of persons with HIV, but some, particularly the pa
APA, Harvard, Vancouver, ISO, and other styles
8

David, Elizabeth. Psychiatric Illness and Treatment in HIV Populations. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0037.

Full text
Abstract:
The interaction between HIV and mental illness is complex. For many individuals, the psychiatric condition is a preexisting one, predisposing to HIV infection through behavioral factors and risk environment. The risk factors for HIV are well established and involve blood/bodily fluid contact with infected individuals: unprotected sexual behaviors, needle sharing, multiple sexual partners, and fetal/natal exposure. Individuals with preexisting psychiatric illness often engage in risky behaviors with little thought or fear of consequences. This relates to increased emotional immaturity and impul
APA, Harvard, Vancouver, ISO, and other styles
9

Maggi, Julie Diana. The impact of attachment style and the physician-patient relationship on adherence to medication treatment in HIV disease. 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Breitbart, William, and Anna L. Dickerman. Fatigue and HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0024.

Full text
Abstract:
Fatigue is commonly reported by persons with HIV and AIDS and is associated with impaired physical function, reduced quality of life, and suboptimal treatment adherence. Patients regard fatigue as an important condition to be addressed because it is disabling and distressing. In the past, fatigue was overlooked and undertreated by physicians, but clinicians caring for persons with HIV and AIDS have been giving more attention to symptom management and patients’ quality of life. Increased attention to symptom management in HIV and AIDS warrants familiarity with major issues in evaluation and tre
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HIV treatment adherence"

1

Goldstein, Karen Moore. "Adherence in the Treatment of HIV and Other Infectious Diseases." In Improving Patient Treatment Adherence. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-5866-2_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Amico, K. Rivet. "Adherence to HIV Treatment as Prevention and Preexposure Prophylaxis." In Biomedical Advances in HIV Prevention. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8845-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Adu-Gyamfi, Eric, and Petter Nielsen. "Leveraging Software Platform Capabilities to Support HIV (ART) Treatment Adherence Management: A Case from Sierra Leone." In Information and Communication Technologies for Development. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59111-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vermorken, Jan B. "Where and when to Use Induction Chemotherapy in Head and Neck Squamous Cell Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_11.

Full text
Abstract:
AbstractThe treatment of locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) is reviewed, highlighting the milestones in systemic therapy in that setting, with focus on the role of induction chemotherapy (ICT). The road to what is now considered the standard ICT regimen, i.e. the TPF (docetaxel/cisplatin/5-FU) regimen is described, and the differences between the European and the American TPF are discussed. The article describes the respective roles of ICT for larynx preservation, for treatment intensification, its role in patients with borderline resectable or unresectable oral cavity cancer, its role as a selection tool for radiotherapy dose de-escalation in patients with oropharyngeal squamous cell cancer (OPSCC) and its potential future role in strategies aiming at synchronous oligometastatic disease.ICT has an established role for organ preservation in advanced laryngeal and hypopharyngeal cancer and the TPF regimen has been validated in that setting. This approach is presently being compared in a randomized controlled trial to concurrent chemoradiotherapy (CCRT), which in many parts of the world is considered the standard organ preservation procedure. There remains uncertainty about the benefit of the sequential approach of ICT followed by CCRT, despite the fact that ICT significantly reduces the occurrence of distant metastases. It is advised that future studies should include patients who have the highest risk to develop distant metastases, in particular patients with low neck nodes and matted nodes. Moreover, further studies in patients with HPV-associated OPSCC at risk for distant failure (T4 or N3 disease) should be considered for that also. These approaches still need to be confirmed in adequately sized randomized controlled trials. Outside clinical trials, the utility of ICT is restricted to uniquely pragmatic clinical scenarios, such as unavoidable delay in radiation or in the situation that RT is not tolerated or feasible. This can happen when there is severe pain from advanced disease or there is impending airway compromise or neurologic dysfunction that necessitates rapid initiation of treatment. In all those circumstances whether within the context of trials or outside trials, it is imperative that the present backbone of ICT, the TPF regimen, is being administered by experienced oncologists, familiar with the necessary protocols and supportive care requirements to ensure patient safety and maximize adherence throughout the treatment.Future areas of research are the role of ICT in strategies whereby ICT is combined with upfront metastases-directed treatments and the usefulness of targeted agents or immune checkpoint inhibitors in the induction setting. Studies in that direction have already started. Finally, the application of radiographic, proteomic and genomic biomarkers will get attention to further define prognostic groups and guide treatment selection with greater precision.
APA, Harvard, Vancouver, ISO, and other styles
5

"The Development and Feasibility of an Intervention to Improve HAART Adherence Among HIV-Positive Patients Receiving Primary Care in Methadone Clinics." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Specialized Adherence Counselors Can Improve Treatment Adherence: Guidelines for Specific Treatment Issues." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Training Substance Abuse Counselors About HIV Medication Adherence." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"More Than Drugs: Voices of HIV-Seropositive Individuals with a History of Substance Use Reveal a Range of Adherence Factors." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Introduction: Addressing Challenges of Adherence to HIV Medications for Social Services Practice, Research, and Training." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"HIV Treatment Adherence Research and Intervention: Current Advances and Future Challenges." In HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HIV treatment adherence"

1

Notario Dongil, C., A. Perez Fácila, B. Proy Vega, MM Alañón Pardo, P. Araque Arroyo, and JC Valenzuela Gámez. "4CPS-064 Adherence to antiretroviral treatment in patients with HIV." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cane, Reka Maulide, Amilcar Magaco, Carlos Botao, Granelio Tamele, and Francisco Mbofana. "p4.121 Care-seeking Behaviours among hiv-infected adults in mozambique: hiv-related knowledge and adherence to treatment." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pangerti, Fitria Diyah Ayu, Pawito Pawito, and Hanung Prasetya. "Factors Affecting Adherence to Antiretroviral Therapy: Application of Theory of Planned Behavior in Malang, East Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.53.

Full text
Abstract:
Background: Adherence to antiretroviral (ARV) treatment is known as an important component in achieving the success of an optimal HIV therapy program. Poor adherence to antiretroviral therapy (ART) is associated with less effective viral suppression, which creating permanent treatment resistance. The purpose of this study was to examine factors affecting adherence to ARV therapy. Subjects and Method: A cross-sectional study was conducted in Malang, East Java, from September to October 2019. A sample of 200 PLWH was selected by fixed disease sampling. The dependent variable was adherence to ARV
APA, Harvard, Vancouver, ISO, and other styles
4

Lake, Joanita, Kendra Lawrence, Elena Martinez Alonso, Valerie Gonzales, and Joanne LaFleur. "24 Quality appraisal of systematic reviews of HIV treatment adherence and guidance to reduce research waste." In EBM Live Abstracts, July 2019, Oxford, UK. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-ebmlive.105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lobis, Yusuf Bachtiyar, Bhisma Murti, and Hanung Prasetya. "Influences of Peer Support Group and Psychosocio- Economic Determinants on Treatment Compliance in Hiv/Aids Patients in Sragen, Central Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.59.

Full text
Abstract:
Background: Adherence to treatment is important to reduce viral replication, improve clinical and immunological conditions, reduce the risk of developing ARV resistance, and reduce the risk of HIV transmission. Peer support is suspected to be one of the factors driving drug intake adherence in patients with chronic disease. This study aimed to examine the influences of peer support and psychosocio-economic determinants on treatment compliance in HIV/AIDS patients. Subjects and Method: This was a case control design study conducted in Sragen, Central Java, Indonesia. A sample of 200 people with
APA, Harvard, Vancouver, ISO, and other styles
6

Usman, Ibiwumi, and Saheed Usman. "P305 Poor adherence predictors and factors associated with treatment failure among HIV seropositive patients in western nigeria." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tshuma, Ndumiso, and Peter Nyasulu. "P4.75 Exploring the relationship between social factors and treatment adherence among clinically stable art patients: structural equation modelling technique." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.570.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rana, Ela, Philippe J. Giabbanelli, Naga H. Balabhadrapathruni, Xiaoyu Li, and Vijay K. Mago. "Exploring the Relationship between Adherence to Treatment and Viral Load through a New Discrete Simulation Model of HIV Infectivity." In SIGSIM-PADS '15: SIGSIM Principles of Advanced Discrete Simulation. ACM, 2015. http://dx.doi.org/10.1145/2769458.2769477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Omonaiye, Olumuyiwa, Pat Nicholson, Snezana Kusljic, and Elizabeth Manias. "P308 Timing of initiation of HIV treatment and level of adherence among pregnant women under option b+ programme in nigeria." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Naldi, Yandri, and Amanah Amanah. "The Role of Patient Characteristics and Group Support to Adherence Treatment in People with HIV/AIDS (PLWHA) in Cirebon City." In International Conference on Agriculture, Social Sciences, Education, Technology and Health (ICASSETH 2019). Atlantis Press, 2020. http://dx.doi.org/10.2991/assehr.k.200402.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HIV treatment adherence"

1

Impact of a community-based, HIV intervention on antiretroviral treatment retention and adherence in Tanzania. Population Council, 2016. http://dx.doi.org/10.31899/hiv7.1013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Adherence to Antiretroviral Therapy in Adults: A Guide for Trainers. Population Council, 2004. http://dx.doi.org/10.31899/hiv15.1000.

Full text
Abstract:
Over the last five years, there has been a rapid change in treatment strategies for HIV infection. With the advent of newer antiretrovirals, treatment has moved from mono-therapy and bi-therapy to triple drug therapy or Highly Active Antiretroviral Therapy. One of the foremost concerns of ARV programs is the ability of people living with HIV/AIDS to maintain near perfect adherence over the long term. To achieve the goal of antiretroviral therapy (ART), undetectable levels of the virus in the blood, patients are required to maintain more than 90–95% adherence. Adherence is defined as a patient’
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!